Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pelvic exenteration--our experience].

K Nedialkov, N Magunska, B Bechev

    Akusherstvo I Ginekologiia
    |February 12, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Pelvic exenteration, a major surgery for advanced gynecologic cancers, involves removing pelvic organs. Careful patient discussion of risks and benefits is crucial due to a high complication rate.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same authorSame journal

    [TRANSVAGINAL LAPAROSCOPY FOR PELVIC ENDOMETRIOSIS.]

    Akusherstvo i ginekologiia·2018
    Same author

    [FEMALE STEROID HORMONES - MODULATORS OF IMMUNE RESPONSE TO GENITAL CHLAMYDIA TRACHOMATIS INFECTION.]

    Akusherstvo i ginekologiia·2018
    Same author

    [LAPAROSCOPIC TREATMENT OF INTRALIGAMENTAL LEIOMYOMA PER MAGNA].

    Akusherstvo i ginekologiia·2016
    Same author

    [PRIMARY CYTOREDUCTIVE SURGERY VERSUS NEOADJUVANT CHEMOTHERARY IN TREATMENT OF ADVANCED OVARIAN CANCER (STAGE III C-IV). OUR AND FOREIGN EXPERIENCE].

    Akusherstvo i ginekologiia·2016
    Same author

    [RECONSTRUCTIVE AND COSMETIC SURGERY IN TREATMENT OF VULVAR CANCER].

    Akusherstvo i ginekologiia·2016
    Same author

    [COMBINED APPLICATION OF FETAL FIBRONECTIN AND INSULIN-LIKE GROWTH FACTOR IN PRETERM DELIVERY DIAGNOSIS--OUR RESULTS].

    Akusherstvo i ginekologiia·2015
    Same journal

    [POST-PARTUM SEPTIC SACROILIITIS- CASE REPORT AND REVIEW.]

    Akusherstvo i ginekologiia·2018
    Same journal

    [NEW TECHNIQUE FOR UTERINE ARTERY IDENTIFICATION.]

    Akusherstvo i ginekologiia·2018
    Same journal

    [ULTRASOUND OF THE PLACENTA. NORMAL FINDINGS AND PLACENTAL ABNORMALITIES: A REVIEW.]

    Akusherstvo i ginekologiia·2018
    Same journal

    [THE ROLE OF COLPOSCOPY AS A METHOD OF METHODOLOGY FOR EARLY AND RAPID ETIOLOGIC DIAGNOSIS IN THE STUDY OF ENDOCERVICITIS CHLAMYDIALIS.]

    Akusherstvo i ginekologiia·2018
    Same journal

    [LAPAROSCOPIC MYOMECTOMY AFTER ULIPRISTAL ACFTATF TRFATMFMT.]

    Akusherstvo i ginekologiia·2018
    See all related articles

    Area of Science:

    • Gynecologic Oncology
    • Surgical Oncology
    • Pelvic Surgery

    Context:

    • Pelvic exenteration is a radical surgical procedure for advanced or recurrent pelvic cancers.
    • It involves the en bloc removal of pelvic organs, including the reproductive tract, bladder, and rectosigmoid.
    • This procedure is primarily indicated in gynecologic oncology for centrally located, advanced, or recurrent malignancies.

    Purpose:

    • To evaluate the outcomes and complications of pelvic exenteration procedures.
    • To analyze the types and frequency of pelvic exenterations performed at a specific institution.
    • To highlight the importance of risk-benefit assessment for patients undergoing this extensive surgery.

    Summary:

    • A retrospective analysis of 46 pelvic exenterations (total, anterior, posterior, modified posterior) performed between 2004-2012.

    Related Experiment Videos

  • Average operative time was 459 minutes with an average blood loss of 1200 ml.
  • Complications were reported in eight patients, indicating a need for careful preoperative counseling.

    • Impact:

    • Provides insights into the feasibility and outcomes of pelvic exenteration in managing complex gynecologic cancers.
    • Emphasizes the significant morbidity associated with pelvic exenteration, necessitating thorough patient selection and informed consent.
    • Contributes to the understanding of surgical management and complication profiles in advanced pelvic malignancies.